Fellowship · Dallas, TX
Sponsored by University of Texas Southwestern Medical Center · Director Matthew Porembka
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 560 citations · Marilyn Leitch
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 759 citations · Marilyn Leitch
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 829 citations · Adam Yopp
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.
The New England journal of medicine · 2022 · 671 citations · Carlos Arteaga
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Lancet (London, England) · 2023 · 469 citations · Adam Yopp
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 390 citations · Marilyn Leitch
A guideline on the molecular ecosystem regulating ferroptosis.
Nature cell biology · 2024 · 243 citations · Herbert Zeh
The multifunctional protein HMGB1: 50 years of discovery.
Nature reviews. Immunology · 2023 · 336 citations · Herbert Zeh